Huntington’s disease and CRISPR-Cas9 treatment
Huntington’s disease (HD), also known as Huntington’s chorea, is a fatal neurodegenerative genetic disorder. The disease has a prevalence of 4 to 10 individuals per 100,000 people and typically affects people of 40 years old (Ross and Tabrizi 2011). From the time of diagnosis, patients succumb to the illness within 15 to 20 years. As … Read more